Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;13(12):30.
doi: 10.1007/s12410-020-09550-2. Epub 2020 Nov 7.

Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update

Affiliations
Review

Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update

Samer Alabed et al. Curr Cardiovasc Imaging Rep. 2020.

Abstract

Purpose of review: This article reviews advances over the past 3 years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T1 mapping, machine learning and ongoing research.

Recent findings: CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging techniques such as myocardial T1 mapping may play a role in the follow-up of selected patients. Myocardial strain may be used as an early marker for right and left ventricular dysfunction and a predictor for mortality. Machine learning has offered a glimpse into future possibilities. Ongoing research of new PH therapies is increasingly using CMR as a clinical endpoint.

Summary: The last 3 years have seen several large studies establishing CMR as a valuable diagnostic and prognostic tool in patients with PH, with CMR increasingly considered as an endpoint in clinical trials of PH therapies. Machine learning approaches to improve automation and accuracy of CMR metrics and identify imaging features of PH is an area of active research interest with promising clinical utility.

Keywords: CMR; Cardiac MRI; Pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare that they no conflict of interest.

Figures

Fig. 1
Fig. 1
Images from right ventricular strain analysis in a patient with PH
Fig. 2
Fig. 2
Machine learning feature map. Features compatible with PH are in red and non-PH features are in green

Similar articles

Cited by

References

    1. •• Kiely DG, Levin D, Hassoun P, Ivy DD, Jone P-N, Bwika J, et al. EXPRESS: statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm Circ. 2019;9(3):2045894019841990. This article provides guidance on the role of the different types of imaging in pulmonary hypertension including cardiac MRI. - PMC - PubMed
    1. Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015;46(4):903–75. - PubMed
    1. Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, et al. Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018;11:e003973. doi: 10.1161/CIRCOUTCOMES.117.003973. - DOI - PMC - PubMed
    1. Gidwani S, Nair A. The burden of pulmonary hypertension in resource-limited settings. Glob Heart. 2014;9:297–310. doi: 10.1016/j.gheart.2014.08.007. - DOI - PubMed
    1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913. - PMC - PubMed